Tower Research Capital LLC (Trc) Equillium, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.39 Billion
Q3 2025

A detailed history of Tower Research Capital LLC (Trc) transactions in Equillium, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 6,406 shares of EQ stock, worth $6,534. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,406

Previous 6,514 1.66%

Holding current value

$6,534

Previous $2,000 350.0%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$0.32 - $2.25 $34 - $243	-108 Reduced 1.66%	6,406 $9,000
Q2 2025 Aug 14, 2025	SELL	$0.29 - $0.5 $88 - $152	-305 Reduced 4.47%	6,514 $2,000
Q1 2025 May 15, 2025	BUY	$0.39 - $0.94 $333 - $804	856 Added 14.36%	6,819 $2,000
Q4 2024 Feb 13, 2025	BUY	$0.6 - $1.38 $3,577 - $8,228	5,963 New	5,963 $4,000
Q1 2024 May 15, 2024	SELL	$0.73 - $3.0 $1,476 - $6,069	-2,023 Reduced 21.56%	7,359 $16,000

Q4 2023 Feb 13, 2024	SELL	$0.48 - $0.74 $244 - $377	-510 Reduced 5.16%	9,382 $6,000
Q3 2023 Nov 14, 2023	SELL	$0.72 - $0.9 $1,891 - $2,364	-2,627 Reduced 20.98%	9,892 $7,000
Q2 2023 Aug 14, 2023	BUY	$0.49 - $0.79 $4,446 - $7,168	9,074 Added 263.4%	12,519 $9,000
Q1 2023 May 09, 2023	SELL	$0.56 - $1.24 $3,314 - $7,339	-5,919 Reduced 63.21%	3,445 $3,000
Q4 2022 Feb 10, 2023	BUY	$0.83 - $2.26 $511 - $1,392	616 Added 7.04%	9,364 $10,000
Q3 2022 Nov 10, 2022	BUY	$1.93 - $3.14 $8,086 - $13,156	4,190 Added 91.93%	8,748 $19,000
Q2 2022 Aug 15, 2022	SELL	$1.69 - $3.26 $1,750 - $3,377	-1,036 Reduced 18.52%	4,558 $9,000
Q1 2022 May 12, 2022	BUY	$2.99 - $4.19 $6,332 - $8,874	2,118 Added 60.93%	5,594 $18,000
Q4 2021 Feb 14, 2022	BUY	$3.77 - $6.99 $13,104 - $24,297	3,476 New	3,476 $13,000
Q3 2021 Nov 15, 2021	SELL	$4.84 - $6.91 $803 - $1,147	-166 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$5.11 - $7.64 $12,131 - $18,137	-2,374 Reduced 93.46%	166 $1,000
Q1 2021 May 17, 2021	SELL	$5.03 - $10.5 $19,959 - $41,664	-3,968 Reduced 60.97%	2,540 $18,000
Q4 2020 Feb 16, 2021	BUY	$3.48 - $6.58 $22,647 - $42,822	6,508 New	6,508 $35,000
Q3 2020 Nov 16, 2020	SELL	$2.78 - $26.5 $10,500 - $100,090	-3,777 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$2.34 - $3.53 $226 - $342	-97 Reduced 2.5%	3,777 $11,000
Q1 2020 May 15, 2020	SELL	$2.3 - $5.5 $5,099 - $12,193	-2,217 Reduced 36.4%	3,874 $10,000
Q4 2019 Feb 07, 2020	BUY	$3.0 - $5.0 $17,502 - $29,170	5,834 Added 2270.04%	6,091 $20,000
Q3 2019 Nov 05, 2019	SELL	$3.31 - $5.6 $11,240 - $19,017	-3,396 Reduced 92.96%	257 $1,000
Q2 2019 Aug 13, 2019	BUY	$5.28 - $8.2 $6,526 - $10,135	1,236 Added 51.14%	3,653 $21,000
Q1 2019 May 14, 2019	SELL	$5.84 - $12.02 $33,585 - $69,127	-5,751 Reduced 70.41%	2,417 $19,000
Q4 2018 Feb 14, 2019	BUY	$6.32 - $19.44 $51,621 - $158,785	8,168 New	8,168 $67,000

Others Institutions Holding EQ

# of Institutions

Shares Held

32.3M

Call Options Held

152K

Put Options Held

View Full List

About Equillium, Inc.

Ticker EQ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,352,100
Market Cap $35M
Description
Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...

More about EQ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Equillium, Inc. Transaction History